Amylyx Pharmaceuticals In... (AMLX)
NASDAQ: AMLX
· Real-Time Price · USD
8.01
-0.40 (-4.76%)
At close: Aug 15, 2025, 3:59 PM
8.00
-0.12%
After-hours: Aug 15, 2025, 04:10 PM EDT
Amylyx Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | -249K | -1.27M | 87.37M | 196.49M | 298.76M | 398M | 380.79M | 294.22M | 191.87M | 93.66M | 22.23M | 345K | 285K | 285K | 285K | 635K | 350K | 350K |
Cost of Revenue | 950K | 8.44M | 125.16M | 134.52M | 138.93M | 136.88M | 25.44M | 18.9M | 13.86M | 8.38M | 3.13M | 334K | 13.02M | 12.92M | 12.89M | 17.89M | 5.03M | 5.02M |
Gross Profit | -1.36M | -9.87M | -37.95M | 61.97M | 159.84M | 261.12M | 355.35M | 275.32M | 178.02M | 85.28M | 19.1M | 11K | -12.73M | -12.63M | -12.61M | -17.25M | -4.68M | -4.67M |
Operating Income | -196.97M | -207.55M | -291.88M | -249.29M | -154.91M | -81.28M | 38.8M | -7.72M | -81.13M | -155.58M | -201.34M | -185.06M | -153.3M | -117.63M | -82.69M | -62.97M | -40.05M | -21.46M |
Interest Income | 9.61M | 11.71M | 13.81M | 15.86M | 16.95M | 16.76M | 16.16M | 14.94M | 11.36M | 7.88M | 4.29M | 1.16M | 566K | 165K | 36K | 6K | 3K | 2K |
Pretax Income | -188.24M | -219.49M | -302.14M | -257.48M | -162.36M | -65.66M | 54.3M | 5.7M | -70.6M | -148.5M | -197.6M | -183.82M | -153.08M | -121.11M | -87.93M | -68.18M | -45.04M | -23.11M |
Net Income | -187.6M | -218.86M | -301.74M | -259.47M | -165.87M | -71.09M | 49.27M | 1.84M | -72.81M | -148.95M | -198.38M | -184.01M | -153.4M | -121.26M | -87.93M | -68.18M | -45.04M | -23.11M |
Selling & General & Admin | 66.25M | 72.26M | 114.33M | 149.47M | 180.37M | 202.11M | 188.36M | 176.96M | 158.18M | 144.78M | 127.13M | 101.2M | 81.61M | 59.28M | 38.93M | 27.94M | 17.59M | 9.93M |
Research & Development | 93.32M | 89.39M | 103.56M | 125.58M | 134.38M | 140.29M | 128.19M | 106.09M | 100.96M | 96.18M | 93.45M | 84.03M | 71.97M | 58.64M | 44.04M | 35.66M | 22.81M | 11.88M |
Other Expenses | 36.2M | 36.2M | 35.46M | 35.63M | -1.06M | -1.15M | -398K | -569K | 118K | 157K | 138K | 79K | -347K | -305K | -286K | -226K | 1K | 1K |
Operating Expenses | 195.78M | 197.85M | 254.09M | 311.26M | 314.75M | 342.4M | 316.54M | 283.05M | 259.14M | 240.96M | 220.58M | 185.24M | 153.3M | 117.63M | 82.69M | 62.97M | 40.05M | 21.46M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3K | 3K | 3K | 4K | 1K | 1K |
Selling & Marketing Expenses | 2.7M | 2.7M | 2.7M | 9.5M | 9.5M | 9.5M | 9.5M | -15.5M | -15.5M | -15.5M | -15.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 196.73M | 206.28M | 379.25M | 445.78M | 453.67M | 479.28M | 341.98M | 301.95M | 273M | 249.24M | 223.57M | 185.41M | 153.3M | 117.63M | 82.69M | 62.97M | 40.05M | 21.46M |
Income Tax Expense | -635K | -635K | -393K | 1.99M | 3.5M | 5.44M | 5.03M | 3.86M | 2.22M | 458K | 774K | 165K | 511K | 337K | 191K | 223K | 2K | 2K |
Shares Outstanding (Basic) | 89.14M | 85.7M | 68.59M | 68.09M | 68.02M | 67.85M | 67.41M | 67.41M | 67.23M | 66.72M | 65.42M | 58.53M | 58.14M | 51.45M | 55.22M | 55.22M | 45.95M | 45.95M |
Shares Outstanding (Diluted) | 89.14M | 85.7M | 68.59M | 68.09M | 68.02M | 67.85M | 69.2M | 69.75M | 70.13M | 70.86M | 65.42M | 58.53M | 58.28M | 51.6M | 55.22M | 55.22M | 45.95M | 45.95M |
EPS (Basic) | -2.5 | -3.11 | -4.44 | -3.82 | -2.44 | -1.04 | 0.73 | 0.01 | -1.22 | -2.48 | -3.43 | -3.29 | -2.79 | -2.34 | -1.73 | -1.41 | -0.99 | -0.51 |
EPS (Diluted) | -2.5 | -3.11 | -4.44 | -3.82 | -2.45 | -1.07 | 0.70 | -0.02 | -1.24 | -2.48 | -3.43 | -3.29 | -2.79 | -2.34 | -1.73 | -1.41 | -0.99 | -0.51 |
EBITDA | -194.88M | -206.81M | -290.98M | -248.25M | -153.78M | -80.08M | 39.89M | -6.76M | -80.29M | -154.92M | -200.85M | -184.76M | -153.16M | -117.59M | -82.67M | -62.93M | -40.02M | -21.45M |
EBIT | -195.56M | -207.55M | -291.88M | -244.75M | -146.68M | -69.24M | 50.84M | -228K | -77.32M | -155.58M | -201.34M | -185.09M | -153.33M | -117.66M | -82.72M | -62.96M | -40.05M | -21.46M |
Depreciation & Amortization | 678K | 745K | 904K | 1.04M | 1.13M | 1.2M | 1.09M | 969K | 832K | 656K | 487K | 327K | 172K | 77K | 52K | 31K | 21K | 11K |